DOCSLIB.ORG

A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer Published OnlineFirst February 7, 2019; DOI: 10.1158/1055-9965.EPI-18-1002 Research Article Cancer Epidemiology, Biomarkers A Comprehensive Analysis of Steroid Hormones & Prevention and Progression of Localized High-Risk Prostate Cancer Eric Levesque 1, Patrick Caron2, Louis Lacombe1,Veronique Turcotte2, David Simonyan3, Yves Fradet1, Armen Aprikian4, Fred Saad5, Michel Carmel6, Simone Chevalier4, and Chantal Guillemette2 Abstract Background: In men with localized prostate cancer who are terone levels were higher in low-risk disease. Associations were undergoing radical prostatectomy (RP), it is uncertain whether observed between adrenal precursors and risk of cancer pro- their systemic hormonal environment is associated with out- gression. In high-risk patients, a one-unit increment in log- comes. The objective of the study was to examine the associ- transformed androstenediol (A5diol) and dehydroepiandros- ation between the circulating steroid metabolome with prog- terone-sulfate (DHEA-S) levels were linked to DFS with HR of nostic factors and progression. 1.47 (P ¼ 0.0017; q ¼ 0.026) and 1.24 (P ¼ 0.043; q ¼ 0.323), Methods: The prospective PROCURE cohort was recruited respectively. Although the number of metastatic events was from 2007 to 2012, and comprises 1,766 patients with local- limited, trends with metastasis-free survival were observed for ized prostate cancer who provided blood samples prior to RP. A5diol (HR ¼ 1.51; P ¼ 0.057) and DHEA-S levels (HR ¼ 1.43; The levels of 15 steroids were measured in plasma using mass P ¼ 0.054). spectrometry, and their association with prognostic factors and Conclusions: In men with localized prostate cancer, our disease-free survival (DFS) was established with logistic regres- data suggest that the preoperative steroid metabolome is sion and multivariable Cox proportional hazard models. associated with the risk of recurrence of high-risk disease. Results: The median follow-up time after surgery was 73.2 Impact: The associations of adrenal androgens with pro- months. Overall, 524 patients experienced biochemical failure gression of localized high-risk disease could help refine hor- and 75 developed metastatic disease. Testosterone and andros- monal strategies for these patients. Introduction (DHT), dehydroepiandrosterone-sulfate (DHEA-S), androstenedi- one (4-Dione or AD), androstanediol-glucuronide (3a-diol-G) and Prostate cancer is the most commonly diagnosed cancer and estradiol (E )—and the risk of developing prostate cancer (2). Also, the second most common cause of cancer-related deaths among 2 another large study did not find any association between prediag- North American men (1). Currently, approximately 85% of nostic circulating hormone levels (testosterone, DHT, E and 3a- newly diagnosed cases of prostate cancer are localized within 2, diol-G) and lethal prostate cancer (3). In the latter study, the the prostate. Despite the fact that sex steroid hormones play a authors did, however, find an association between an increased central role in prostate biology, a collaborative analysis of risk of lethal prostate cancer with higher prediagnostic levels of 18 prospective studies failed to demonstrate an association DHT in men with aggressive Gleason score (GS) 8 and stage T3 between six circulating steroids—testosterone, dihydrotestosterone disease (3). Results from phase III chemoprevention trials further support 1Centre Hospitalier Universitaire (CHU) de Quebec Research Centre and Faculty the role of sex steroid hormones in prostate cancer carcinogen- fi a of Medicine, Laval University, Quebec, Canada. 2CHU de Quebec Research esis (4, 5). Indeed, nasteride (a 5 -reductase type I inhibitor) Centre and Faculty of Pharmacy, Laval University, Quebec, Canada. 3Statistical and dutasteride (a dual 5-AR inhibitor targeting 5a-reductase type and Clinical Research Platform, CHU de Quebec Research Centre, Quebec, I and type II), both of which block the conversion of testosterone Canada. 4McGill University Health Centre, McGill University, Faculty of Medicine, into DHT in target cells, reduced the occurrence of prostate cancer 5 Quebec, Canada. Centre Hospitalier de l'Universite de Montreal, Faculty of by approximately 25% (4, 5). However, this reduction in prostate 6 Medicine, Universite de Montreal, Quebec, Canada. Universite de Sherbrooke, cancer risk comes at the expense of a controversial but potentially Faculty of Medicine, Quebec, Canada. increased risk of developing higher-grade prostate cancer (4, 5). Note: Supplementary data for this article are available at Cancer Epidemiology, In agreement with the finasteride and dutasteride findings, in Biomarkers & Prevention Online (http://cebp.aacrjournals.org/). men with a confirmed diagnosis of prostate cancer, previous Corresponding Authors: Eric Levesque, CHU de Quebec Research Centre and studies have suggested that low pretreatment levels of serum Laval University, 2705 Blvd. Laurier, Quebec G1V 4G2, Canada. Phone: 418-525- testosterone are associated with disease aggressiveness and clin- 4444; Fax: 418-654-2761; E-mail: [email protected]; and ical outcomes (6, 7). Chantal Guillemette, [email protected] However, other circulating hormones may contribute to clin- doi: 10.1158/1055-9965.EPI-18-1002 ical outcomes in men with localized disease. This is reinforced by Ó2019 American Association for Cancer Research. the fact that cancer cells possess the intracrine biosynthesis www.aacrjournals.org 701 Downloaded from cebp.aacrjournals.org on September 26, 2021. © 2019 American Association for Cancer Research. Published OnlineFirst February 7, 2019; DOI: 10.1158/1055-9965.EPI-18-1002 Levesque et al. surgeons. Serial prostate-specific antigen (PSA) measurements and clinical data were gathered during follow-up. A total of 1,908 single preoperative blood samples were available for steroid analysis. One hundred and forty-two patients were documented to have a prior exposure to a 5a-reductase inhibitor and, therefore, were excluded from the analyses leaving a total of 1,766 patients for this study. No other forms of hormonal manipulation were administered before blood sampling. The objective of the study was the assessment of associations of steroid hormone levels with prostate cancer prognostic factors and progression. After prosta- tectomy, patients were seen regularly and PSA was measured every 3 months for 2 years, every 4–6 months for 2 years, and then every 6–12 months or at the discretion of the physicians. Disease-free survival (DFS) was defined as the occurrence of biochemical recurrence (BCR), metastasis, and/or death (all-causes). BCR was defined as (i) the occurrence of a first PSA >0.2 ng/mL any time after surgery or (ii) a detectable PSA of <0.2 ng/mL that triggered initiation of salvage radiation or androgen abla- tion therapy (10–13). Before surgery, each patient provided written informed consent for research and the protocol was evaluated and approved by the Centre Hospitalier Universitaire (CHU) de Quebec (Quebec, Canada) and local Ethical Research Committees. Figure 1. Simplified schematic representation of the 15 steroid hormones measured in the PROCURE cohort. Steroids were profiled by multiplex MS assays in Plasma steroid measurements by MS preoperative plasma samples except for androstanedione (A-dione) and Blood samples were collected and processed at a preoperative androstane-3a-17b-diol (3a-diol). Abbreviations: testo, testosterone; 3b-diol, visit and banked at À80 C until analyzed. LC/MS-MS and GC-MS androstane-3b,17b-diol; 3a-diol-17G, androstane-3a,17b-diol-17-glucuronide. were used to measure plasma steroid levels as described previ- ously (Fig. 1; ref. 14). Ten unconjugated steroids were measured in a single assay using 250 mL of plasma, whereas sulfates and machinery to locally synthesize active androgens from precursors glucuronides were measured in two independent assays using such as DHEA-S, dehydroepiandrosterone (DHEA), 4-Dione or 20 mL and 100 mL of plasma, respectively. Analyses were per- AD, and androstenediol (A5diol) originating from extragonadal formed in a blinded fashion. Reference steroids were purchased peripheral sources, such as the adrenal glands (Fig. 1; refs. 8, 9). To from Steraloids. Internal standards (deuterated steroids) were our knowledge, a comprehensive assessment of the circulating added to samples and quality controls were included in each hormonal environment including precursors associated with run. The measured steroids and their limits of quantification were disease aggressiveness and clinical outcomes in men with newly as follows: DHEA, 100 pg/mL; progesterone (Prog), 50 pg/mL; diagnosed localized prostate cancer has not been assessed. This A5diol, 50 pg/mL; testosterone, 30 pg/mL; DHT, 10 pg/mL; lack of information is mostly due to the fact that the majorities of androsterone (AST), 50 pg/mL; androstane-3b,17b-diol (3b- previous studies conducted in localized disease were mostly Diol), 10 pg/mL; estrone (E1), 5 pg/mL; estradiol (E2), 1 pg/mL; focused on testosterone and relied on low specificity and accuracy 4-Dione or AD, 50 pg/mL; AST-glucuronide (AST-G), 1 ng/mL; radioimmunoassays measuring a single hormone at a time. The androstane-3a,17b-diol-3-glucuronide (3a-diol-3G), 0.25 ng/ use of gold standard mass spectrometry (MS) methods for accu- mL; androstane-3a,17b-diol-17-glucuronide (3a-diol-17-G), rate and specific assessment of various steroids is thus critical. 0.25 ng/mL; DHEA-S, 0.075 mg/mL; estrone-sulfate (E1-S), In this
Load more

Recommended publications
  • Estrone Sulfate
    Available online at www.sciencedirect.com Journal of Steroid Biochemistry & Molecular Biology 109 (2008) 158–167 Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa)ଝ Frank Giton a,∗, Alexandre de la Taille b, Yves Allory b, Herve´ Galons c, Francis Vacherot b, Pascale Soyeux b, Claude Clement´ Abbou b, Sylvain Loric b, Olivier Cussenot b, Jean-Pierre Raynaud d, Jean Fiet b a AP-HP CIB INSERM IMRB U841eq07, Henri Mondor, Facult´edeM´edecine, 94010 Cr´eteil, France b INSERM IMRB U841 eq07, CHU Henri Mondor, Facult´edeM´edecine, 94010 Cr´eteil, France c Service de Chimie organique, Facult´e de Pharmacie Paris V, 75006 Paris, France d Universit´e Pierre et Marie Curie, 75252 Paris, France Received 26 December 2006; accepted 26 October 2007 Abstract Seeking insight into the possible role of estrogens in prostate cancer (PCa) evolution, we assayed serum E2, estrone (E1), and estrone sulfate (E1S) in 349 PCa and 100 benign prostatic hyperplasia (BPH) patients, and in 208 control subjects in the same age range (50–74 years). E1 (pmol/L ± S.D.) and E1S (nmol/L ± S.D.) in the PCa and BPH patients (respectively 126.1 ± 66.1 and 2.82 ± 1.78, and 127.8 ± 56.4 and 2.78 ± 2.12) were significantly higher than in the controls (113.8 ± 47.6 and 2.11 ± 0.96). E2 was not significantly different among the PCa, BPH, and control groups. These assays were also carried out in PCa patients after partition by prognosis (PSA, Gleason score (GS), histological stage, and surgical margins (SM)).
    [Show full text]
  • Neurosteroid Metabolism in the Human Brain
    European Journal of Endocrinology (2001) 145 669±679 ISSN 0804-4643 REVIEW Neurosteroid metabolism in the human brain Birgit Stoffel-Wagner Department of Clinical Biochemistry, University of Bonn, 53127 Bonn, Germany (Correspondence should be addressed to Birgit Stoffel-Wagner, Institut fuÈr Klinische Biochemie, Universitaet Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany; Email: [email protected]) Abstract This review summarizes the current knowledge of the biosynthesis of neurosteroids in the human brain, the enzymes mediating these reactions, their localization and the putative effects of neurosteroids. Molecular biological and biochemical studies have now ®rmly established the presence of the steroidogenic enzymes cytochrome P450 cholesterol side-chain cleavage (P450SCC), aromatase, 5a-reductase, 3a-hydroxysteroid dehydrogenase and 17b-hydroxysteroid dehydrogenase in human brain. The functions attributed to speci®c neurosteroids include modulation of g-aminobutyric acid A (GABAA), N-methyl-d-aspartate (NMDA), nicotinic, muscarinic, serotonin (5-HT3), kainate, glycine and sigma receptors, neuroprotection and induction of neurite outgrowth, dendritic spines and synaptogenesis. The ®rst clinical investigations in humans produced evidence for an involvement of neuroactive steroids in conditions such as fatigue during pregnancy, premenstrual syndrome, post partum depression, catamenial epilepsy, depressive disorders and dementia disorders. Better knowledge of the biochemical pathways of neurosteroidogenesis and
    [Show full text]
  • Convergence of Multiple Mechanisms of Steroid Hormone Action
    Review 569 Convergence of Multiple Mechanisms of Steroid Hormone Action Authors S. K. Mani 1 * , P. G. Mermelstein 2 * , M. J. Tetel 3 * , G. Anesetti 4 * Affi liations 1 Department of Molecular & Cellular Biology and Neuroscience, Baylor College of Medicine, Houston, TX, USA 2 Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA 3 Neuroscience Program, Wellesley College, Wellesley, MA, USA 4 Departamento de Hostologia y Embriologia, Facultad de Medicine, Universidad de la Republica, Montevideo, Uruguay Key words Abstract receptors can also be activated in a “ligand-inde- ● ▶ estrogen ▼ pendent” manner by other factors including neu- ● ▶ progesterone Steroid hormones modulate a wide array of rotransmitters. Recent studies indicate that rapid, ▶ ● signaling physiological processes including development, nonclassical steroid eff ects involve extranuclear ● ▶ cross-talk metabolism, and reproduction in various species. steroid receptors located at the membrane, which ● ▶ ovary ● ▶ brain It is generally believed that these biological eff ects interact with cytoplasmic kinase signaling mol- are predominantly mediated by their binding to ecules and G-proteins. The current review deals specifi c intracellular receptors resulting in con- with various mechanisms that function together formational change, dimerization, and recruit- in an integrated manner to promote hormone- ment of coregulators for transcription-dependent dependent actions on the central and sympathetic genomic actions (classical mechanism). In addi- nervous systems. tion, to their cognate ligands, intracellular steroid Abbreviations gene expression and function. Interestingly, not ▼ all the “classical” receptors are intranuclear and CBP CREB binding protein can be associated at the membrane. As described CRE CREB response element in this review, extranuclear ERs and PRs at the DAR Dopamine receptor (DAR) membrane or in the cytoplasm can interact with ER Estrogen receptor G proteins and signaling kinases, and other G received 13 .
    [Show full text]
  • Alteration of the Steroidogenesis in Boys with Autism Spectrum Disorders
    Janšáková et al. Translational Psychiatry (2020) 10:340 https://doi.org/10.1038/s41398-020-01017-8 Translational Psychiatry ARTICLE Open Access Alteration of the steroidogenesis in boys with autism spectrum disorders Katarína Janšáková 1, Martin Hill 2,DianaČelárová1,HanaCelušáková1,GabrielaRepiská1,MarieBičíková2, Ludmila Máčová2 and Daniela Ostatníková1 Abstract The etiology of autism spectrum disorders (ASD) remains unknown, but associations between prenatal hormonal changes and ASD risk were found. The consequences of these changes on the steroidogenesis during a postnatal development are not yet well known. The aim of this study was to analyze the steroid metabolic pathway in prepubertal ASD and neurotypical boys. Plasma samples were collected from 62 prepubertal ASD boys and 24 age and sex-matched controls (CTRL). Eighty-two biomarkers of steroidogenesis were detected using gas-chromatography tandem-mass spectrometry. We observed changes across the whole alternative backdoor pathway of androgens synthesis toward lower level in ASD group. Our data indicate suppressed production of pregnenolone sulfate at augmented activities of CYP17A1 and SULT2A1 and reduced HSD3B2 activity in ASD group which is partly consistent with the results reported in older children, in whom the adrenal zona reticularis significantly influences the steroid levels. Furthermore, we detected the suppressed activity of CYP7B1 enzyme readily metabolizing the precursors of sex hormones on one hand but increased anti-glucocorticoid effect of 7α-hydroxy-DHEA via competition with cortisone for HSD11B1 on the other. The multivariate model found significant correlations between behavioral indices and circulating steroids. From dependent variables, the best correlation was found for the social interaction (28.5%). Observed changes give a space for their utilization as biomarkers while reveal the etiopathogenesis of ASD.
    [Show full text]
  • The Relationship Between Serum Sex Steroid Levels and Heart Rate Variability Parameters in Males and the Effect Of
    Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2010;38(7):459-465 459 The relationship between serum sex steroid levels and heart rate variability parameters in males and the effect of age Erkeklerde serum cinsiyet steroidleri ile kalp hızı değişkenliği verileri arasındaki ilişki ve yaşın etkileri M. Tolga Doğru, M.D., M. Murad Başar, M.D.,# Ercan Yuvanç, M.D.,# Vedat Şimşek, M.D., Ömer Şahin, M.D. Departments of Cardiology and #Urology, Medicine Faculty of Kırıkkale University, Kırıkkale Objectives: We evaluated the relationships between sex Amaç: Bu çalışmada cinsiyet steroidleri ile kalp hızı de- steroid levels and heart rate variability (HRV) parameters. ğişkenliği (KHD) verileri arasındaki ilişkiler araştırıldı. Study design: The study included 114 male subjects (mean Çalışma planı: Çalışmaya, kardiyolojik açıdan değerlen- age 46.6±11.3 years) presenting to our department for cardi- dirme için başvuran 114 erkek hasta (ort. yaş 46.6±11.3) ologic evaluation. Hormonal analysis included serum levels alındı. Hormon analizlerinde serumda luteinize edici hor- of luteinizing hormone, prolactin, total testosterone (TT), free mon, prolaktin, total testosteron (TT), serbest testosteron, testosterone, estradiol (E2), and dehydroepiandrosterone östradiol (E2) ve dehidroepiandrosteron sülfat (DHEA-S) sulfate (DHEA-S). Parameters of HRV were derived from düzeyleri ölçüldü. Yirmi dört saatlik Holter kayıtlarından 24-hour Holter monitoring. The associations between serum KHD parametreleri hesaplandı. Serum cinsiyet steroidleri sex steroid levels and HRV parameters were investigated in ile KHD değerleri arasındaki ilişkiler hastalar üç yaş gru- three age groups (20-39 years; 40-59 years; >60 years). buna (20-39 yaş; 40-59 yaş; >60 yaş) ayrılarak incelendi.
    [Show full text]
  • Conjugated and Unconjugated Plasma Androgens in Normal Children
    Pediat. Res. 6: 111-118 (1972) Androstcncdionc sexual development dehydroepiandrosterone testosterone Conjugated and Unconjugated Plasma Androgens in Normal Children DONALD A. BOON,'291 RAYMOND E. KEENAN, W. ROY SLAUNWHITE, JR., AND THOMAS ACETO, JR. Children's Hospital, Medical Foundation of Buffalo, Roswell Park Memorial Institute, and Departments of Biochemistry and Pediatrics, School of Medicine, State University of New York at Buffalo, Buffalo, New York, USA Extract Methods developed in this laboratory permit measurement of the androgens, testos- terone (T), dehydroepiandrosterone (D), and androstenedione (A) on a 10-ml sample of plasma. We have determined concentrations of the unconjugated androgens (T, A, D) as well as of the sulfates of dehydroepiandrosterone (DS) and androsterone (AS) in the plasma of 85 healthy children of both sexes from birth through the age of 20 years. Our results are shown and summarized, along with those of other investigators. Mean plasma concentrations Sex and age ng/100 ml Mg/100 ml T A D AS DS Male Neonates 39 24 30 None detectable None detectable 1-8 years 25 58 64 2 11 9-20 years 231 138 237 28 74 Female Neonates 36 30 83 None detectable None detectable 1-8 years 11 69 54 5 20 9-20 years 28 84 164 22 44 Testosterone was elevated in both sexes in the newborn as compared with the 1-8- year-old group. In contrast, sulfated androgens, with one exception, were undetectable early in life. In males, there was a marked rise in all androgens, especially T, in the 9-18-year-old group.
    [Show full text]
  • Dehydroepiandrosterone an Inexpensive Steroid Hormone That Decreases the Mortality Due to Sepsis Following Trauma-Induced Hemorrhage
    PAPER Dehydroepiandrosterone An Inexpensive Steroid Hormone That Decreases the Mortality Due to Sepsis Following Trauma-Induced Hemorrhage Martin K. Angele, MD; Robert A. Catania, MD; Alfred Ayala, PhD; William G. Cioffi, MD; Kirby I. Bland, MD; Irshad H. Chaudry, PhD Background: Recent studies suggest that male sex ste- hemorrhage and resuscitation, the animals were killed roids play a role in producing immunodepression follow- and blood, spleens, and peritoneal macrophages were har- ing trauma-hemorrhage. This notion is supported by stud- vested. Splenocyte proliferation and interleukin (IL) 2 ies showing that castration of male mice before trauma- release and splenic and peritoneal macrophage IL-1 and hemorrhage or the administration of the androgen receptor IL-6 release were determined. In a separate set of experi- blocker flutamide following trauma-hemorrhage in non- ments, sepsis was induced by cecal ligation and punc- castrated animals prevents immunodepression and im- ture at 48 hours after trauma-hemorrhage and resusci- proves the survival rate of animals subjected to subse- tation. For those studies, the animals received vehicle, a quent sepsis. However, it remains unknown whether the single 100-µg dose of DHEA, or 100 µg/d DHEA for 3 most abundant steroid hormone, dehydroepiandros- days following hemorrhage and resuscitation. Survival terone (DHEA), protects or depresses immune functions was monitored for 10 days after the induction of sepsis. following trauma-hemorrhage. In this regard, DHEA has been reported to have estrogenic and androgenic proper- Results: Administration of DHEA restored the de- ties, depending on the hormonal milieu. pressed splenocyte and macrophage functions at 24 hours after trauma-hemorrhage.
    [Show full text]
  • Low Testosterone (Hypogonadism)
    Low Testosterone (Hypogonadism) Testosterone is an anabolic-androgenic steroid hormone which is made in the testes in males (a minimal amount is also made in the adrenal glands). Testosterone has two major functions in the human body. Testosterone production is regulated by hormones released from the brain. The brain and testes work together to keep testosterone in the normal range (between 199 ng/dL and 1586 ng/dL) Testosterone is needed to form and maintain the male sex organs, regulate sex drive (libido) and promote secondary male sex characteristics such as voice deepening and development of facial and body hair. Testosterone facilitates muscle growth as well as bone development and maintenance. Low testosterone levels in the blood are seen in males with a medical condition known as Hypogonadism. This may be due to a signaling problem between the brain and testes that can cause production to slow or stop. Hypogonadism can also be caused by a problem with production in the testes themselves. Causes Primary: This type of hypogonadism — also known as primary testicular failure — originates from a problem in the testicles. Secondary: This type of hypogonadism indicates a problem in the hypothalamus or the pituitary gland — parts of the brain that signal the testicles to produce testosterone. The hypothalamus produces gonadotropin- releasing hormone, which signals the pituitary gland to make follicle-stimulating hormone (FSH) and luteinizing hormone. Luteinizing hormone then signals the testes to produce testosterone. Either type of hypogonadism may be caused by an inherited (congenital) trait or something that happens later in life (acquired), such as an injury or an infection.
    [Show full text]
  • Analysis of Anabolic Steroid Glucuronide and Sulfate Conjugates
    Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle Blokland, M.H.; Tricht, E.F. van; Ginkel L.A. van; Sterk, S.S. This is a "Post-Print" accepted manuscript, which has been published in “Catena” This version is distributed under a non-commencial no derivatives Creative Commons (CC-BY-NC-ND) user license, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and not used for commercial purposes. Further, the restriction applies that if you remix, transform, or build upon the material, you may not distribute the modified material. Please cite this publication as follows: Blokland, M.H.; Tricht, E.F. van; Ginkel L.A. van; Sterk, S.S. (2017) Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle. The Journal of Steroid Biochemistry and Molecular Biology 174, p. 265-275 You can download the published version at: https://doi.org/10.1016/j.jsbmb.2017.10.007 Applicability of an innovative steroid-profiling method to determine synthetic growth promoter abuse in cattle 5 M.H. Blokland*, E.F. van Tricht, L.A van Ginkel, S.S. Sterk RIKILT Wageningen University & Research, P.O. Box 230, Wageningen, The Netherlands 10 *Corresponding author: M.H. Blokland, Tel.: +31 317 480417, E-mail: [email protected] 15 Keywords: synthetic steroids, growth promoters, cattle, UHPLC-MS/MS, steroid profiling, steroidogenesis Abstract 20 A robust LC-MS/MS method was developed to quantify a large number of phase I and phase II steroids in urine.
    [Show full text]
  • Plasma Membrane Receptors for Steroid Hormones in Cell Signaling and Nuclear Function
    Chapter 5 / Plasma Membrane Receptors for Steroids 67 5 Plasma Membrane Receptors for Steroid Hormones in Cell Signaling and Nuclear Function Richard J. Pietras, PhD, MD and Clara M. Szego, PhD CONTENTS INTRODUCTION STEROID RECEPTOR SIGNALING MECHANISMS PLASMA MEMBRANE ORGANIZATION AND STEROID HORMONE RECEPTORS INTEGRATION OF MEMBRANE AND NUCLEAR SIGNALING IN STEROID HORMONE ACTION MEMBRANE-ASSOCIATED STEROID RECEPTORS IN HEALTH AND DISEASE CONCLUSION 1. INTRODUCTION Steroid hormones play an important role in coordi- genomic mechanism is generally slow, often requiring nating rapid, as well as sustained, responses of target hours or days before the consequences of hormone cells in complex organisms to changes in the internal exposure are evident. However, steroids also elicit and external environment. The broad physiologic rapid cell responses, often within seconds (see Fig. 1). effects of steroid hormones in the regulation of growth, The time course of these acute events parallels that development, and homeostasis have been known for evoked by peptide agonists, lending support to the con- decades. Often, these hormone actions culminate in clusion that they do not require precedent gene activa- altered gene expression, which is preceded many hours tion. Rather, many rapid effects of steroids, which have earlier by enhanced nutrient uptake, increased flux of been termed nongenomic, appear to be owing to spe- critical ions, and other preparatory changes in the syn- cific recognition of hormone at the cell membrane. thetic machinery of the cell. Because of certain homo- Although the molecular identity of binding site(s) logies of molecular structure, specific receptors for remains elusive and the signal transduction pathways steroid hormones, vitamin D, retinoids, and thyroid require fuller delineation, there is firm evidence that hormone are often considered a receptor superfamily.
    [Show full text]
  • Standardization of Steroid Hormone Assays: Why, How, and When?
    1713 Commentary Standardization of Steroid Hormone Assays: Why, How, and When? Frank Z. Stanczyk,1 Jennifer S. Lee,2 and Richard J. Santen3 1Departments of Obstetrics and Gynecology, and Preventive Medicine, University of Southern California, KeckSchool of Medicine, Women’s and Children’s Hospital, Los Angeles, California; 2Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, Department of Internal Medicine, University of California at Davis, Sacramento, California; and 3Clinical Research, Cancer Center, University of Virginia, Charlottesville, Virginia Abstract Lack of standardization of high-quality steroid hor- lation with biological variables such as body mass mone assays is a major deficiency in epidemiologic index. Similar problems exist with measurements of studies. In postmenopausal women, reported levels of E2 and estrone in men, and estrone and testosterone B serum17 -estradiol (E2) are highly variable and median in women. Interest in mass spectrometry–based assays normal values differ by approximately a 6-fold factor. is increasing as potential gold standard methods with A particular problemis the use of E 2 assays for pre- enhanced sensitivity and specificity; however, these diction of breast cancer risk and osteoporotic fractures, assays require costly instrumentation and highly where assay sensitivity may be the most important trained personnel. Taking all of these issues into con- factor. Identification of women in the lowest categories sideration, we propose establishment of standard pools of E2 levels will likely provide prognostic information of premenopausal, postmenopausal, and male serum, that would not be available in a large group of women and utilization of these for cross-comparison of various in whomE 2 levels are undetectable by less sensitive methods on an international basis.
    [Show full text]
  • Documentation, Codebook, and Frequencies
    Documentation, Codebook, and Frequencies Surplus Sera Laboratory Component: Racial/Ethnic Variation In Sex Steroid Hormone Concentrations Across Age In US Men Survey Years: 1988 to 1991 SAS Export File: SSHORMON.XPT First Published: October 2006 Last revised: N/A NHANES III Data Documentation Laboratory Assessment: Racial/Ethnic Variation in Sex Steroid Hormone Concentrations Across Age In US Men (NHANES III Surplus Sera) Years of Coverage: 1988-1991 First Published: October 2006 Last Revised: N/A Introduction It has been proposed that racial/ethnic variation in prostate cancer incidence may be, in part, due to racial/ethnic variation in sex steroid hormone levels. However, it remains unclear whether in the US population circulating concentrations of sex steroid hormones vary by race/ethnicity. To address this, concentrations of testosterone, sex hormone binding globulin, androstanediol glucuronide (a metabolite of dihydrotestosterone) and estradiol were measured in stored serum specimens from men examined in the morning sample of the first phase of NHANES III (1988-1991). This data file contains results of the testing of 1637 males age 12 or more years who participated in the morning examination of phase 1 of NHANES III and for whom serum was still available in the repository. Data Documentation for each of these four components is given in sections below. I. Testosterone Component Summary Description The androgen testosterone (17β -hydroxyandrostenone) has a molecular weight of 288 daltons. In men, testosterone is synthesized almost exclusively by the Leydig cells of the testes. The secretion of testosterone is regulated by luteinizing hormone (LH), and is subject to negative feedback via the pituitary and hypothalamus.
    [Show full text]